| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GANX | Gain Therapeutics, Inc. | Eric I. Richman | Director | Jul 01, 2024 | Buy | $1.22 | 17,000 | 20,670 | 289,629 | Jul 01, 2024, 05:00 PM | |
| GANX | Gain Therapeutics, Inc. | Eric I. Richman | Director | Sep 20, 2023 | Option/RSU Exercise | - | 54,900 | - | 272,629 | Sep 22, 2023, 04:34 PM | |
| GANX | Gain Therapeutics, Inc. | Eric I. Richman | CHIEF EXECUTIVE OFFICER | May 25, 2022 | Buy | $2.58 | 2,482 | 6,404 | 217,729 | May 27, 2022, 04:10 PM | |
| GANX | Gain Therapeutics, Inc. | Eric I. Richman | CHIEF EXECUTIVE OFFICER | May 20, 2022 | Buy | $2.83 | 9,256 | 26,194 | 215,247 | May 23, 2022, 04:41 PM | |
| GANX | Gain Therapeutics, Inc. | Eric I. Richman | CHIEF EXECUTIVE OFFICER | May 19, 2022 | Buy | $2.71 | 4,000 | 10,840 | 205,991 | May 23, 2022, 04:41 PM | |
| GANX | Gain Therapeutics, Inc. | Eric I. Richman | Chief Executive Officer | Aug 16, 2021 | Buy | $7.87 | 4,922 | 38,716 | 216,820 | Apr 21, 2022, 04:50 PM | |
| GANX | Gain Therapeutics, Inc. | Eric I. Richman | Director | Aug 16, 2021 | Option/RSU Exercise | $7.87 | 4,922 | 38,716 | 216,820 | Aug 17, 2021, 09:03 PM | |
| ADMA | ADMA BIOLOGICS, INC. | Eric I. Richman | Director | Jun 08, 2018 | Buy | $4.78 | 5,230 | 24,999 | 36,530 | Jun 11, 2018, 07:08 AM | |
| ADMA | ADMA BIOLOGICS, INC. | Eric I. Richman | Director | Nov 09, 2017 | Buy | $2.15 | 25,000 | 53,750 | 31,300 | Nov 13, 2017, 01:51 PM | |
| ADMA | ADMA BIOLOGICS, INC. | Eric I. Richman | Director | Jul 13, 2017 | Option/RSU Exercise | $2.68 | 2,800 | 7,504 | 6,300 | Jul 17, 2017, 05:12 PM | |
| PIP | PHARMATHENE, INC | Eric I. Richman | Director | Nov 22, 2016 | Option/RSU Exercise | $1.85 | 483,733 | 895,213 | 898,055 | Nov 23, 2016, 04:46 PM | |
| PIP | PHARMATHENE, INC | Eric I. Richman | Director | Sep 28, 2016 | Option/RSU Exercise | $1.45 | 237,500 | 343,625 | 414,322 | Sep 30, 2016, 04:33 PM | |
| PIP | PHARMATHENE, INC | Eric I. Richman | Director | Apr 13, 2016 | Option/RSU Exercise | $1.19 | 329,354 | 392,240 | 326,822 | Apr 15, 2016, 07:53 PM | |
| PIP | PHARMATHENE, INC | Eric I. Richman | Director | Apr 13, 2016 | Sale | $2.20 | 329,354 | 724,579 | 176,822 | Apr 15, 2016, 07:53 PM | |
| PIP | PHARMATHENE, INC | Eric I. Richman | Director | Apr 08, 2016 | Sale | $2.20 | 6,400 | 14,080 | 176,822 | Apr 11, 2016, 06:18 PM | |
| PIP | PHARMATHENE, INC | Eric I. Richman | Director | Apr 07, 2016 | Option/RSU Exercise | $1.76 | 5,367 | 9,446 | 182,189 | Apr 11, 2016, 06:18 PM | |
| PIP | PHARMATHENE, INC | Eric I. Richman | Director | Apr 07, 2016 | Sale | $2.20 | 5,367 | 11,807 | 176,822 | Apr 11, 2016, 06:18 PM | |
| PIP | PHARMATHENE, INC | Eric I. Richman | Director | Apr 08, 2016 | Option/RSU Exercise | $1.76 | 6,400 | 11,264 | 183,222 | Apr 11, 2016, 06:18 PM | |
| ADMA | ADMA BIOLOGICS, INC. | Eric I. Richman | Director | Mar 13, 2015 | Buy | $7.88 | 3,500 | 27,570 | 3,500 | Mar 17, 2015, 08:43 PM | |
| PIP | PHARMATHENE, INC | Eric I. Richman | President and CEO | Nov 10, 2011 | Buy | $1.50 | 10,000 | 15,025 | 4,500 | Nov 14, 2011, 06:51 AM | |
| PIP | PHARMATHENE, INC | Eric I. Richman | See Remarks | Mar 23, 2010 | Tax Payment (Shares) | $3.40 | 10,500 | 35,700 | 99,322 | May 12, 2011, 06:55 PM | |
| PIP | PHARMATHENE, INC | Eric I. Richman | See Remarks | Jan 21, 2011 | Tax Payment (Shares) | $3.42 | 3,057 | 10,455 | 109,822 | Jan 25, 2011, 05:00 PM | |
| PIP | PHARMATHENE, INC | Eric I. Richman | President and CEO | Nov 03, 2010 | Conversion | $2.54 | 7,306 | 18,570 | 77,879 | Nov 05, 2010, 08:32 PM |